Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis
Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Read bone head pumper , the COMPANY BELIEVES not FDA not HC
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(165)
•••
Comment by KVDollarson Oct 14, 2021 8:03pm
114 Views
Post# 34007472

RE:Read bone head pumper , the COMPANY BELIEVES not FDA not HC

RE:Read bone head pumper , the COMPANY BELIEVES not FDA not HC We get it Sam you are a basher :P it makes sense... all your post is on TBP.. If you had one once of shares here,,, you wouldnt be doing what you do.

Its easy to spot all your comments its just TBP related... You are obviously a paid basher.... which one of the bankers sent you here so that you can make it easy for them to short.


LOL
very easy to spot


SamV21 wrote: The Company believes that these two characteristics of its drug-device combination product are critical for an effective drug in the management of breakthrough pain.

MEANS NOTHING BEEN SAYING THIS FOR 4 YEARS , THE COMPANY BELIEVES.Classic words from Guys go fund me page.


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities